by EmpathiCSubstanceS | Nov 25, 2019 | Depression
Psilocybin, the psychoactive compound found naturally in “magic mushrooms,” has shown promising results in treating anxiety and depression. A recently published study reinforces that potential, demonstrating that depressed patients treated with psilocybin...
by EmpathiCSubstanceS | Nov 24, 2019 | Alcoholism
Supplementing psychotherapy with small doses of MDMA could be an effective strategy to prevent relapses of alcohol addiction in patients, an ongoing small clinical trial suggests. The research is yet another example of how scientists and doctors are finding or...
by EmpathiCSubstanceS | Nov 24, 2019 | Addiction
The heavy hallucinogen ibogaine is illegal in the US, but some addicts are flocking to Mexican clinics for it, hoping to be cured. A physician investigates. ILLUSTRATION: YUKAI DU I’m not sure I’ve ever met an opioid user who didn’t want to quit, and as an emergency...
by EmpathiCSubstanceS | Sep 9, 2019 | Anxiety
The research center, with $17 million from donors, aims to give “psychedelic medicine” a long-sought foothold in the scientific establishment. Since childhood, Rachael Petersen had lived with an unexplainable sense of grief that no drug or talk therapy could entirely...
by EmpathiCSubstanceS | Aug 2, 2019 | Pain
Psychedelics Take the TED Talk Stage for the First Time Preparing for this talk has been scarier for me than preparing for LSD therapy,” began Rick Doblin, the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), in his...
